Overview
Qiaoyun Tan practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Alveolar Soft Part Sarcoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Diffuse Large B-Cell Lymphoma (DLBCL).
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Qiaoyun Tan
Is Qiaoyun Tan a top-rated expert for Alveolar Soft Part Sarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Qiaoyun Tan is classified as an Experienced expert for Alveolar Soft Part Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Qiaoyun Tan participate in research or clinical trials?
Yes. Qiaoyun Tan has published 16 articles and abstracts on conditions like Alveolar Soft Part Sarcoma. You can view a list of Qiaoyun Tan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alveolar Soft Part Sarcoma
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Lung AdenocarcinomaTan isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerTan isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)